Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04839198 · ClinicalTrials.gov registry record · NA
Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking Cessation
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT04839198: Completed NA study, sponsored by The University of Texas Health Science Center, Houston.
NCT04839198 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04839198, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility and preliminary effectiveness of delivering a personalized, just-in-time adaptive intervention driven by machine learning prediction of smoking lapse risk in real time.
Interventions
- DRUG Nicotine Patch
- BEHAVIORAL Android Wear smartwatch
- BEHAVIORAL Adaptive Treatment
- BEHAVIORAL interviewing-based counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-02-06 |
| Est. Completion | 2024-11-22 |
| Phase | NA |
What the finished NCT04839198 record still lists
NCT04839198 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 4 interventions - of which Nicotine Patch is the first listed.
NCT04839198 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04839198 about?
NCT04839198 is a clinical study titled "Using Machine Learning to Develop Just-in-Time Adaptive Interventions for Smoking Cessation". The purpose of this study is to evaluate the feasibility and preliminary effectiveness of delivering a personalized, just-in-time adaptive intervention driven by machine learning prediction of smoking lapse risk in real time.
What is the current status of trial NCT04839198?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-06. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT04839198?
The interventions under investigation include: Nicotine Patch (DRUG), Android Wear smartwatch (BEHAVIORAL), Adaptive Treatment (BEHAVIORAL), interviewing-based counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT04839198?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04839198's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI